OTC Line Extensions Cause Confusion, Medical Errors, USP Members State
This article was originally published in The Tan Sheet
Executive Summary
A resolution concerning the reduction of medical errors through labeling and packaging standards would apply to OTC drugs, the U.S. Pharmacopeia's Resolutions Committee decided at USP's quinquennial meeting in Washington, D.C. April 12-16.
You may also be interested in...
Brand Name Confusion Preventable Under Existing Regs, Industry Rep Says
Established brand history and OTC labeling rules provide consumers with enough information to avoid confusing self-care products carrying similar brand names and different active ingredients, Consumer Healthcare Products Association General Counsel Eve Bachrach told an FDA panel June 28.
Brand Name Confusion Preventable Under Existing Regs, Industry Rep Says
Established brand history and OTC labeling rules provide consumers with enough information to avoid confusing self-care products carrying similar brand names and different active ingredients, Consumer Healthcare Products Association General Counsel Eve Bachrach told an FDA panel June 28.
Brand Name Confusion Preventable Under Existing Regs, Industry Rep Says
Established brand history and OTC labeling rules provide consumers with enough information to avoid confusing self-care products carrying similar brand names and different active ingredients, Consumer Healthcare Products Association General Counsel Eve Bachrach told an FDA panel June 28.